BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Hassan K, Bhalla V, Regal MEE, A-Kader HH. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic. World J Gastroenterol 2014; 20(34): 12082-12101 [PMID: 25232245 DOI: 10.3748/wjg.v20.i34.12082]
URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12082.htm
(390) (379) (0) (0) (18189) (151)
Number Citing Articles
1
Ha-Neul Choi, Jin-Yeong Shin, Jung-In Kim. Ameliorative Effect of Myricetin on Nonalcoholic Fatty Liver Disease in ob/ob Mice. Journal of Medicinal Food 2021; 24(10) doi: 10.1089/jmf.2021.K.0090
2
Pegah Jahani, Mohammad Reza Fattahi, Mojtaba Neydavoodi, Zeinab Gholami. Correlation of Liver Fibroscan Results with Liver Elastographyand Liver Enzymes in Patients with Fatty Liver. Journal of Kermanshah University of Medical Sciences 2024; 29(1) doi: 10.5812/jkums-142386
3
Ghulam Fatima, Kaneez Zainab Rabail, Mona Humaira, Afsana Khaskheli, Benazir Bughio, Kashaf Nida. Frequency of Liver Fibrosis by Non Invasive Marker in Patients with Non-Alcohol Fatty Liver Diseases. Pakistan Journal of Health Sciences 2023;  doi: 10.54393/pjhs.v4i02.572
4
Elena Buzzetti, Massimo Pinzani, Emmanuel A. Tsochatzis. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016; 65(8) doi: 10.1016/j.metabol.2015.12.012
5
Bubu A. Banini, Arun J. Sanyal. Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. Clinical Medicine Insights: Therapeutics 2016; 8 doi: 10.4137/CMT.S18885
6
Fahad Alshagathrh, Mahmood Alzubaidi, Samuel Gecík, Khalid Alswat, Ali Aldhebaib, Bushra Alahmadi, Meteb Alkubeyyer, Abdulaziz Alosaimi, Amani Alsadoon, Maram Alkhamash, Jens Schneider, Mowafa Househ. Hybrid Deep Learning and Machine Learning for Detecting Hepatocyte Ballooning in Liver Ultrasound Images. Diagnostics 2024; 14(23) doi: 10.3390/diagnostics14232646
7
Lin Zhou, Huiyu Gao, Jiabin Zhang, Qian Xu, Qiang Wang, Li Wang, Ying Tan, Ziyuan Luo, Junjie Zhou, Hui Shuai, Xiang Cai, Yongbo Zheng, Shan Wang, Xi Duan, Tao Wu. Metabolic syndrome and cancer risk: a two-sample Mendelian randomization study of European ancestry. International Journal of Surgery 2025; 111(1) doi: 10.1097/JS9.0000000000001926
8
O. M. Drapkina, R. N. Shepel, E. P. Yakovenko, E. V. Zyatenkova. Non-invasive methods for detection of progressive fibrosis in patients with nonalcoholic fat liver disease. Profilakticheskaya meditsina 2019; 22(2) doi: 10.17116/profmed20192202182
9
Banrida Wahlang, Jordan T. Perkins, Michael C. Petriello, Jessie B. Hoffman, Arnold J. Stromberg, Bernhard Hennig. A compromised liver alters polychlorinated biphenyl-mediated toxicity. Toxicology 2017; 380 doi: 10.1016/j.tox.2017.02.001
10
Tsuyoshi Uchida, Koichi Fujiwara, Kenichi Nishioji, Masao Kobayashi, Manabu Kano, Yuya Seko, Kanji Yamaguchi, Yoshito Itoh, Hiroshi Kadotani. Medical checkup data analysis method based on LiNGAM and its application to nonalcoholic fatty liver disease. Artificial Intelligence in Medicine 2022; 128 doi: 10.1016/j.artmed.2022.102310
11
. 2023;  doi: 10.70675/31d71663zbb02z4de1z8d85z71e3821a3141
12
Reshmi Morris, Ronald Feinstein, Martin Fisher. Laboratory screening in overweight/obese adolescents: do the results change the management?. International Journal of Adolescent Medicine and Health 2017; 29(5) doi: 10.1515/ijamh-2015-0102
13
Jiajing Zhao, Yingjue Wang, Xi Wu, Ping Tong, Yaohan Yue, Shurong Gao, Dongping Huang, Jianwei Huang. Inhibition of CCL19 benefits non‑alcoholic fatty liver disease by inhibiting TLR4/NF‑κB‑p65 signaling. Molecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.9490
14
Dengcheng Hui, Lu Liu, Nisma Lena Bahaji Azami, Jingru Song, Yanping Huang, Wan Xu, Chao Wu, Dong Xie, Yulang Jiang, Yanqin Bian, Mingyu Sun. The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial. Frontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1107071
15
Lan N. Tu, Megan R. Showalter, Tomas Cajka, Sili Fan, Viju V. Pillai, Oliver Fiehn, Vimal Selvaraj. Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05040-6
16
Mi Ji Jeong, Sang Ryong Kim, Un Ju Jung. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet. Nutrition Research 2019; 64 doi: 10.1016/j.nutres.2019.01.001
17
Po-Hsiang Tsui, Yung-Liang Wan. Effects of Fatty Infiltration of the Liver on the Shannon Entropy of Ultrasound Backscattered Signals. Entropy 2016; 18(9) doi: 10.3390/e18090341
18
Tae-In Hwang, A-Lum Han. Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease. International Journal of Environmental Research and Public Health 2021; 18(24) doi: 10.3390/ijerph182413145
19
Polyana C. Marinho, Aline B. Vieira, Priscila G. Pereira, Kíssila Rabelo, Bianca T. Ciambarella, Ana L. R. Nascimento, Erika Cortez, Aníbal S. Moura, Fernanda V. Guimarães, Marco A. Martins, Gonzalo Barquero, Rodrigo N. Ferreira, Jorge J. de Carvalho, Yuan Xu. Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/4956079
20
Emma J. Robinson, Matthew C. Taddeo, Xin Chu, Weixing Shi, Craig Wood, Christopher Still, Virginia G. Rovnyak, David Rovnyak. Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted 1H-NMR Metabolomics. Metabolites 2021; 11(11) doi: 10.3390/metabo11110737
21
Nengguang Fan, Lijuan Zhang, Zhenhua Xia, Liang Peng, Yufan Wang, Yongde Peng. Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients. Journal of Diabetes Research 2016; 2016 doi: 10.1155/2016/3805372
22
Mélanie Kirchmeyer, Florence A Servais, Matthias Hamdorf, Petr V Nazarov, Aurélien Ginolhac, Rashi Halder, Laurent Vallar, Matthias Glanemann, Claudia Rubie, Frank Lammert, Stephanie Kreis, Iris Behrmann. Cytokine-mediated modulation of the hepatic miRNome: miR-146b-5p is an IL-6-inducible miRNA with multiple targets. Journal of Leukocyte Biology 2018; 104(5) doi: 10.1002/JLB.MA1217-499RR
23
Lu Gan, Zi-jun Meng, Ri-bo Xiong, Jin-qiang Guo, Xiao-cui Lu, Zhi-wei Zheng, Yan-ping Deng, Bing-de Luo, Fei Zou, Hua Li. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. Acta Pharmacologica Sinica 2015; 36(5) doi: 10.1038/aps.2015.11
24
Richard M. Woodford, Paul R. Burton, Paul E. O’Brien, Cheryl Laurie, Wendy A. Brown. Laparoscopic Adjustable Gastric Banding In Patients with Unexpected Cirrhosis: Safety and Outcomes. Obesity Surgery 2015; 25(10) doi: 10.1007/s11695-015-1623-9
25
Sofia G. Verstraete, Janet M. Wojcicki, Emily R. Perito, Philip Rosenthal. Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003–2010. Environmental Health 2018; 17(1) doi: 10.1186/s12940-018-0356-3
26
Zhuhuang Zhou, Dar-In Tai, Yung-Liang Wan, Jeng-Hwei Tseng, Yi-Ru Lin, Shuicai Wu, Kuen-Cheh Yang, Yin-Yin Liao, Chih-Kuang Yeh, Po-Hsiang Tsui. Hepatic Steatosis Assessment with Ultrasound Small-Window Entropy Imaging. Ultrasound in Medicine & Biology 2018; 44(7) doi: 10.1016/j.ultrasmedbio.2018.03.002
27
Ziqi Chen, Fang Liu, Nanxin Zheng, Meng Guo, Leilei Bao, Yangyang Zhan, Mingjian Zhang, Yuanyu Zhao, Wenyuan Guo, Guoshan Ding. Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development. Biomedicine & Pharmacotherapy 2019; 110 doi: 10.1016/j.biopha.2018.11.069
28
Man Gong, Chengfu Su, Mengzhe Fan, Ping Wang, Bingdi Cui, Zhongyuan Guo, Shaojia Liang, Lianhe Yang, Xiaoqian Liu, Liping Dai, Zhimin Wang. Mechanism by which Eucommia ulmoides leaves Regulate Nonalcoholic fatty liver disease based on system pharmacology. Journal of Ethnopharmacology 2022; 282 doi: 10.1016/j.jep.2021.114603
29
Long Wang, Jinghui Guo, Jianping Lu. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females. Oncotarget 2016; 7(24) doi: 10.18632/oncotarget.9691
30
Ewa Stachowska, Karina Ryterska, Dominika Maciejewska, Marcin Banaszczak, Piotr Milkiewicz, Małgorzata Milkiewicz, Izabela Gutowska, Piotr Ossowski, Małgorzata Kaczorowska, Dominika Jamioł-Milc, Anna Sabinicz, Małgorzata Napierała, Lidia Wądołowska, Joanna Raszeja-Wyszomirska. Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR). International Journal of Molecular Sciences 2016; 17(7) doi: 10.3390/ijms17071192
31
Llilda Barata, Mary F. Feitosa, Lawrence F. Bielak, Brian Halligan, Abigail S. Baldridge, Xiuqing Guo, Laura M. Yerges‐Armstrong, Albert V. Smith, Jie Yao, Nicholette D. Palmer, Lisa B. VanWagner, J. Jeffrey Carr, Yii‐Der I. Chen, Matthew Allison, Matthew J. Budoff, Samuel K. Handelman, Sharon L.R. Kardia, Thomas H. Mosley, Kathleen Ryan, Tamara B. Harris, Lenore J. Launer, Vilmundur Gudnason, Jerome I. Rotter, Myriam Fornage, Laura J. Rasmussen‐Torvik, Ingrid B. Borecki, Jeffrey R. O’Connell, Patricia A. Peyser, Elizabeth K. Speliotes, Michael A. Province. Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes. Hepatology Communications 2019; 3(7) doi: 10.1002/hep4.1353
32
Laleh Farzin, Elahe Mansouri, Shiva Salehi, Emma Baker, Farshad Amirkhizi, Somayyeh Asghari. Effects of resveratrol supplementation on serum concentrations of plasminogen activator inhibitor-1, fibroblast growth factor 21, and adiponectin in patients with nonalcoholic fatty liver disease. BMC Nutrition 2025; 11(1) doi: 10.1186/s40795-025-00997-4
33
Rong Zhang, Keran Cheng, Shizan Xu, Sainan Li, Yuqing Zhou, Shunfeng Zhou, Rui Kong, Linqiang Li, Jingjing Li, Jiao Feng, Liwei Wu, Tong Liu, Yujing Xia, Jie Lu, Chuanyong Guo, Yingqun Zhou. Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Gastroenterology Research and Practice 2017; 2017 doi: 10.1155/2017/8491742
34
Mazen Noureddin, Alice Zhang, Rohit Loomba. Promising therapies for treatment of nonalcoholic steatohepatitis. Expert Opinion on Emerging Drugs 2016; 21(3) doi: 10.1080/14728214.2016.1220533
35
Kimberley D. Bruce, Dawid Szczepankiewicz, Kiran K. Sihota, Manoj Ravindraanandan, Hugh Thomas, Karen A. Lillycrop, Graham C. Burdge, Mark A. Hanson, Christopher D. Byrne, Felino R. Cagampang. Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2016; 1861(7) doi: 10.1016/j.bbalip.2016.03.026
36
Shoukat Ali Samejo, Zaigham Abbas, Muhammad Asim. Effects of anthropometric and metabolic parameters on transaminase levels and liver stiffness in patients with non-alcohol fatty liver disease. Tropical Doctor 2021; 51(2) doi: 10.1177/0049475520962742
37
Zeyu Li, Hong Wang, Kanglin Wu, Lianfeng Zhang. Omarigliptin protects against nonalcoholic fatty liver disease by ameliorating oxidative stress and inflammation. Journal of Biochemical and Molecular Toxicology 2021; 35(12) doi: 10.1002/jbt.22914
38
Manash Pratim Pathak, Kalyani Pathak, Riya Saikia, Urvashee Gogoi, Pompy Patowary, Pronobesh Chattopadhyay, Aparoop Das. Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review. Heliyon 2023; 9(4) doi: 10.1016/j.heliyon.2023.e15347
39
Laurent Dollé, Neil D. Theise, Eva Schmelzer, Luke Boulter, Olivier Gires, Leo A. van Grunsven. EpCAM and the biology of hepatic stem/progenitor cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(4) doi: 10.1152/ajpgi.00069.2014
40
Bin Li, Qi Xiao, Jianuo Zhang, Yumeng Wang, Jiushi Liu, Bengang Zhang, Haitao Liu. Exploring the active compounds and potential mechanism of the anti-nonalcoholic fatty liver disease activity of the fraction from Schisandra chinensis fruit extract based on multi-technology integrated network pharmacology. Journal of Ethnopharmacology 2023; 301 doi: 10.1016/j.jep.2022.115769
41
Nicolai Worm. Schützt moderater Weinkonsum vor nichtalkoholischer Fettleber?. 38th World Congress of Vine and Wine (Part 2) 2015;  doi: 10.1051/oivconf/201508001
42
Nicolai Worm. Schützt moderater Weinkonsum vor nichtalkoholischer Fettleber?. 38th World Congress of Vine and Wine (Part 2) 2015;  doi: 10.1051/oivconf/201508001
43
Arshad Mehmood, Lei Zhao, Yong Wang, Fei Pan, Shuai Hao, Huimin Zhang, Asra Iftikhar, Muhammad Usman. Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive review. Food Research International 2021; 142 doi: 10.1016/j.foodres.2021.110180
44
Lauren Weaver, Abdul-rizaq Hamoud, David E. Stec, Terry D. Hinds. Biliverdin reductase and bilirubin in hepatic disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 314(6) doi: 10.1152/ajpgi.00026.2018
45
Yue Liu, Jian-Ying Sheng, Chun-Fang Yang, Junjun Ding, Yun-Shen Chan. A decade of liver organoids: Advances in disease modeling. Clinical and Molecular Hepatology 2023; 29(3) doi: 10.3350/cmh.2022.0428
46
Lijing Zhang, Bin Yang, Baoping Yu. Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. Biological & Pharmaceutical Bulletin 2015; 38(7) doi: 10.1248/bpb.b14-00892
47
Steven E. Trasino, Xiao-Han Tang, Jose Jessurun, Lorraine J. Gudas. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease. Journal of Molecular Medicine 2016; 94(10) doi: 10.1007/s00109-016-1434-z
48
Amina A. Negash, Michael Gale. Hepatitis regulation by the inflammasome signaling pathway. Immunological Reviews 2015; 265(1) doi: 10.1111/imr.12279
49
Nengguang Fan, Liang Peng, Zhenhua Xia, Lijuan Zhang, Yufan Wang, Yongde Peng. Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00073
50
María Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, Francisco Barrera, Dimitri P Mikhailidis. Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review. Current Vascular Pharmacology 2024; 22(3) doi: 10.2174/0115701611285401240110074530
51
Yvonne Alt, Jörn M. Schattenberg. Derzeit bleiben als Gegenmittel nur Aufmerksamkeit und Lebensstilmodifikation. Info Diabetologie 2015; 9(1) doi: 10.1007/s15034-014-0624-4
52
Rendong Ren, Junjie Gong, Yanyan Zhao, Xinyun Zhuang, Yin Ye, Wenting Lin. Sulfated polysaccharides from Enteromorpha prolifera suppress SREBP-2 and HMG-CoA reductase expression and attenuate non-alcoholic fatty liver disease induced by a high-fat diet. Food & Function 2017; 8(5) doi: 10.1039/C7FO00103G
53
Qian He, Xuan Xia, Kecheng Yao, Jun Zeng, Wei Wang, Qiong Wu, Renmin Tang, Xiulan Zou. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell. Life Sciences 2019; 239 doi: 10.1016/j.lfs.2019.117010
54
WEI CHEN, XIAOWEI WANG, LI HUANG, BO LIU. Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway. Experimental and Therapeutic Medicine 2016; 11(1) doi: 10.3892/etm.2015.2873
55
José A Del Campo, Paloma Gallego, Lourdes Grande. Role of inflammatory response in liver diseases: Therapeutic strategies. World Journal of Hepatology 2018; 10(1): 1-7 doi: 10.4254/wjh.v10.i1.1
56
Stephen I. Johnson, Daniel Fort, Kenneth J. Shortt, George Therapondos, Gretchen E. Galliano, Theresa Nguyen, Edward I. Bluth. Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index. Diagnostics 2021; 11(8) doi: 10.3390/diagnostics11081443
57
Fernando Ezquer, Javiera Bahamonde, Ya-Lin Huang, Marcelo Ezquer. Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy. Stem Cell Research & Therapy 2017; 8(1) doi: 10.1186/s13287-016-0469-y
58
L. Farzin, S. Asghari, M. Rafraf, M. Asghari-Jafarabadi, M. Shirmohammadi. No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease. International Journal for Vitamin and Nutrition Research 2020; 90(3-4) doi: 10.1024/0300-9831/a000528
59
Corinn Marakovits, Heather Francis. Unraveling the complexities of fibrosis and ductular reaction in liver disease: pathogenesis, mechanisms, and therapeutic insights. American Journal of Physiology-Cell Physiology 2024; 326(3) doi: 10.1152/ajpcell.00486.2023
60
Shahla Rezaei, Masoumeh Akhlaghi, Mohammad Reza Sasani, Reza Barati Boldaji. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial. Nutrition 2019; 57 doi: 10.1016/j.nut.2018.02.021
61
Junbo Gao, Lifeng Zhang, Gaiqing Yu, Guoqiang Qu, Yanfeng Li, Xuebing Yang. Model with the GBDT for Colorectal Adenoma Risk Diagnosis. Current Bioinformatics 2020; 15(9) doi: 10.2174/1574893614666191120142005
62
Ali Mehmood Alkassar, Batool Abed Alnaby Shaker Alaboudy. Effect of added different levels of Graviola Leavs meal ( Annona muricata L) on biochemical blood traits and bacteriological account in broilers chicken. IOP Conference Series: Earth and Environmental Science 2021; 735(1) doi: 10.1088/1755-1315/735/1/012023
63
Reem Hatem, Faisal A Nawaz, Ghadah A Al-Sharif, Mohammad Almoosa, Wid Kattan, Christos Tzivinikos, E Lila Amirali, Ammar Albanna. Nonalcoholic Fatty Liver Disease in Children and Adolescents Taking Atypical Antipsychotic Medications: Protocol for a Systematic Review and Meta-analysis. JMIR Research Protocols 2022; 11(3) doi: 10.2196/20168
64
Hyung-Jin Yoo, Jong-Ha Lee, Soo-Kyung Lee, Yung-Sun Song. Effects ofBangkibokryeong-tang(Fangjifuling-tang) on the Reduction of Blood Glucose and Body Fat in High Fat Diet Induced Obese Mice. Journal of Korean Medicine Rehabilitation 2017; 27(1) doi: 10.18325/jkmr.2017.27.1.1
65
Ram B. Jain, Alan Ducatman. Selective Associations of Recent Low Concentrations of Perfluoroalkyl Substances With Liver Function Biomarkers. Journal of Occupational & Environmental Medicine 2019; 61(4) doi: 10.1097/JOM.0000000000001532
66
Sajida Perveen, Muhammad Shahbaz, Karim Keshavjee, Aziz Guergachi. A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20166-x
67
Rishi Rikhi, Tavankit Singh, Jamak Modaresi Esfeh. Work up of fatty liver by primary care physicians, review. Annals of Medicine and Surgery 2020; 50 doi: 10.1016/j.amsu.2020.01.001
68
Nengguang Fan, Xiaoying Ding, Qin Zhen, Liping Gu, Aifang Zhang, Tingting Shen, Yufan Wang, Yongde Peng. Association of the Non‐Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross‐sectional study in China. Journal of Diabetes Investigation 2021; 12(6) doi: 10.1111/jdi.13430
69
Masoumeh Atefi, Mohammad Hassan Entezari, Hamid Vahedi, Akbar Hassanzadeh, Marta Laranjo. Sesame Oil Ameliorates Alanine Aminotransferase, Aspartate Aminotransferase, and Fatty Liver Grade in Women with Nonalcoholic Fatty Liver Disease Undergoing Low‐Calorie Diet: A Randomized Double‐Blind Controlled Trial. International Journal of Clinical Practice 2022; 2022(1) doi: 10.1155/2022/4982080
70
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. La utilidad clínica de la elastografía transitoria como una herramienta de imagenología para evaluar el impacto a corto plazo de la gastrectomía laparoscópica en manga, en conjunto con parámetros clínicos y bioquímicos e índices clínico-bioquímicos en pacientes con enfermedad de hígado graso no alcohólico: un estudio piloto egipcio. Revista de Gastroenterología de México 2021; 86(2) doi: 10.1016/j.rgmx.2020.04.007
71
Cari Coscia, Ernest Saxton, Sharon Dickinson. Postoperative Care of a Liver Transplant Recipient Using a Classification System. Critical Care Nursing Quarterly 2016; 39(3) doi: 10.1097/CNQ.0000000000000119
72
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
73
Saverio Nucera, Rosa Maria Bulotta, Stefano Ruga, Rosamaria Caminiti, Maria Serra, Roberto Bava, Fabio Castagna, Carmine Lupia, Mariangela Marrelli, Filomena Conforti, Giancarlo Statti, Vincenzo Mollace, Ernesto Palma. Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. Scientia Pharmaceutica 2023; 91(4) doi: 10.3390/scipharm91040053
74
Hua Cai, Yue-Lan Qin, Ze-Ya Shi, Jin-Hui Chen, Min-Jie Zeng, Wei Zhou, Ru-Qun Chen, Zhi-Yuan Chen. Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1132-8
75
Charlotte S Benson, Jeremy F Cobbold, Charlotte J Frise. Non-alcoholic fatty liver disease in pregnancy. Obstetric Medicine 2023; 16(2) doi: 10.1177/1753495X211034709
76
Manuel F. Landecho, Víctor Valentí, Rafael Moncada, Gema Frühbeck. Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology 2017; 960 doi: 10.1007/978-3-319-48382-5_23
77
Almudena Veiga-Lopez, Yong Pu, Jeremy Gingrich, Vasantha Padmanabhan. Obesogenic Endocrine Disrupting Chemicals: Identifying Knowledge Gaps. Trends in Endocrinology & Metabolism 2018; 29(9) doi: 10.1016/j.tem.2018.06.003
78
Ann Hammarstedt, Silvia Gogg, Shahram Hedjazifar, Annika Nerstedt, Ulf Smith. Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity. Physiological Reviews 2018; 98(4) doi: 10.1152/physrev.00034.2017
79
Timothy D. Rohrbach, Amon Asgharpour, Melissa A. Maczis, David Montefusco, L. Ashley Cowart, Pierre Bedossa, Arun J. Sanyal, Sarah Spiegel. FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. Journal of Lipid Research 2019; 60(7) doi: 10.1194/jlr.M093799
80
Samira Abdollahi, Abbas Sahebghadam Lotfi, Ramin Saravani, Hamed Taheri. An association study of SERPINA1 gene polymorphisms with the risk of metabolic dysfunction-associated steatotic liver disease In an Iranian population: A preliminary case-control study. Biochemistry and Biophysics Reports 2025; 42 doi: 10.1016/j.bbrep.2025.101974
81
Lucas Zangerolamo, Jean F. Vettorazzi, Lucas R.O. Rosa, Everardo M. Carneiro, Helena C.L. Barbosa. The bile acid TUDCA and neurodegenerative disorders: An overview. Life Sciences 2021; 272 doi: 10.1016/j.lfs.2021.119252
82
Sonu Subudhi, Hannah K. Drescher, Laura E. Dichtel, Lea M. Bartsch, Raymond T. Chung, Matthew M. Hutter, Denise W. Gee, Ozanan R. Meireles, Elan R. Witkowski, Louis Gelrud, Ricard Masia, Stephanie A. Osganian, Jenna L. Gustafson, Steve Rwema, Miriam A. Bredella, Sangeeta N. Bhatia, Andrew Warren, Karen K. Miller, Georg M. Lauer, Kathleen E. Corey. Distinct Hepatic Gene‐Expression Patterns of NAFLD in Patients With Obesity. Hepatology Communications 2022; 6(1) doi: 10.1002/hep4.1789
83
Zi Zeng, Yuejuan Dong, Hua Wei, Sijin Sun, Zhuoma Sunu. Which oil truly benefits patients with metabolic dysfunction-associated steatotic liver disease? A systematic review and network meta-analysis. Nutrition Clinique et Métabolisme 2026; 40(3) doi: 10.1016/j.nupar.2026.103055
84
Minal Patel. Evidence-based management of patients with nonalcoholic fatty liver disease. JAAPA 2022; 35(8) doi: 10.1097/01.JAA.0000840492.53680.59
85
Harleen K. Dyal, Maria Aguilar, Taft Bhuket, Benny Liu, Edward W. Holt, Sharon Torres, Ramsey Cheung, Robert J. Wong. Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review. Digestive Diseases and Sciences 2015; 60(9) doi: 10.1007/s10620-015-3760-3
86
Sara Ashtari, Mohamad Amin Pourhoseingholi, Mohamad Reza Zali. Non-alcohol fatty liver disease in Asia: Prevention and planning. World Journal of Hepatology 2015; 7(13): 1788-1796 doi: 10.4254/wjh.v7.i13.1788
87
Francisco Javier Ruiz-Ojeda, Andrea Méndez-Gutiérrez, Concepción María Aguilera, Julio Plaza-Díaz. Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases. International Journal of Molecular Sciences 2019; 20(19) doi: 10.3390/ijms20194888
88
Hui Cheng, Na Xu, Wenxia Zhao, Jingjing Su, Mengru Liang, Zhongwen Xie, Xianli Wu, Qinglin Li. (‐)‐Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high‐fat diet. Molecular Nutrition & Food Research 2017; 61(11) doi: 10.1002/mnfr.201700303
89
Rendong Ren, Zheng Yang, Aili Zhao, Yuyang Huang, Shiying Lin, Junjie Gong, Jie Chen, Pingping Zhu, Fang Huang, Wenting Lin. Sulfated polysaccharide from Enteromorpha prolifera increases hydrogen sulfide production and attenuates non-alcoholic fatty liver disease in high-fat diet rats. Food & Function 2018; 9(8) doi: 10.1039/C8FO00518D
90
Arkadip Choudhury, Avik Chakraborty, Animesh Saha. STATUS OF 25-HYDROXYVITAMIN D LEVELS AND SERUM CONCENTRATION OF PROINFLAMMATORY CYTOKINES (IL-6 AND TNF-Α) IN MIDDLE-AGED TRIBAL SUBJECTS OF TRIPURA. Journal of Evolution of Medical and Dental Sciences 2018; 7(45) doi: 10.14260/jemds/2018/1080
91
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker. Pathogenesis of nonalcoholic steatohepatitis. Cellular and Molecular Life Sciences 2016; 73(10) doi: 10.1007/s00018-016-2161-x
92
Saeed Hamid, Amna Subhan Butt, Fatima Sharif, Zishan Haider, Mohammad Salih, Safia Awan, Aatif A Khan, Jaweed Akhter. Nonalcoholic Fatty Liver Diseases among Recently Diagnosed Patients with Diabetes Mellitus and Risk Factors. Euroasian Journal of Hepato-Gastroenterology 2019; 9(1) doi: 10.5005/jp-journals-10018-1288
93
. 2019;  doi: 10.70675/47517b92z4e00z41e1z828dzd86aa45af704
94
Jinhyuk Na, Soo An Choi, Adnan Khan, Joo Young Huh, Lingjuan Piao, Inah Hwang, Hunjoo Ha, Youngja H Park. Integrative Omics Reveals Metabolic and Transcriptomic Alteration of Nonalcoholic Fatty Liver Disease in Catalase Knockout Mice. Biomolecules & Therapeutics 2019; 27(2) doi: 10.4062/biomolther.2018.175
95
Stephanie Breher-Esch, Nishika Sahini, Anna Trincone, Christin Wallstab, Jürgen Borlak. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease. BMC Medical Genomics 2018; 11(1) doi: 10.1186/s12920-018-0438-7
96
Masoumeh Akhlaghi. Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids. Phytotherapy Research 2016; 30(10) doi: 10.1002/ptr.5667
97
Lizhi Fu, Antje Bruckbauer, Fenfen Li, Qiang Cao, Xin Cui, Rui Wu, Hang Shi, Michael B. Zemel, Bingzhong Xue. Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice. Metabolism 2015; 64(11) doi: 10.1016/j.metabol.2015.07.006
98
Anna Radziejewska, Agata Muzsik, Fermín I. Milagro, J. Alfredo Martínez, Agata Chmurzynska. One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. Lifestyle Genomics 2020; 13(2) doi: 10.1159/000504602
99
Naser Khalaji, Ahad Zeinali, Masomeh Purjabali, Kia Bolurani, Amin Abdollahazade Fard. The Effect of Bioactive Component of Turmeric (curcumin) on Liver Complications - Induced by Compact Fluorescent Lamps (CFLs) in Rats. Shiraz E-Medical Journal 2018; (In Press) doi: 10.5812/semj.60572
100
Aayed Alqahtani, Mohamed Elahmedi, Khalid Alswat, Maha Arafah, Mosa Fagih, Jaehoon Lee. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. Surgery for Obesity and Related Diseases 2017; 13(9) doi: 10.1016/j.soard.2017.04.005
101
Love Sharma, Divya Gupta, Sheikh Tasduq Abdullah. Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASH. Toxicology Letters 2019; 304 doi: 10.1016/j.toxlet.2019.01.001
102
Belend Ismail, Puria Nabilou, Lise Lotte Gluud, Søren Møller. Cardiovascular implications of MASLD: overview of the evidence. Scandinavian Journal of Gastroenterology 2025; 60(9) doi: 10.1080/00365521.2025.2536585
103
Momoka Yamaguchi, Naoki Dohi, Akira Ooka, Shin-ya Saito, Tomohisa Ishikawa. Caffeine-induced inversion of prostaglandin E2 effects on hepatic stellate cell activation. Biomedicine & Pharmacotherapy 2021; 142 doi: 10.1016/j.biopha.2021.111989
104
A Al-Radaideh, R Tayyem, K Al-Fayomi, N Nimer, A Almomani, S Alhajjaj, L Agraib, N Hijjawi. The association of hepatic fat percentage with selected anthropometric and biochemical parameters at 3-Tesla magnetic resonance imaging. British Journal of Biomedical Science 2019; 76(2) doi: 10.1080/09674845.2019.1571555
105
Somayyeh Asghari, Mohammad Asghari-Jafarabadi, Mohammad-Hossein Somi, Seyed-Mostafa Ghavami, Maryam Rafraf. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. Journal of the American College of Nutrition 2018; 37(3) doi: 10.1080/07315724.2017.1392264
106
Agnieszka Zwolak, Agnieszka Szuster-Ciesielska, Jadwiga Daniluk, Olga Słabczyńska, Martyna Kandefer-Szerszeń, Patricia Aspichueta. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate. PLOS ONE 2015; 10(12) doi: 10.1371/journal.pone.0143851
107
Martin Duncan, Wenjing Zong, Vincent F. Biank, Joseph R. Hageman. Nonalcoholic Fatty Liver Disease in Pediatrics. Pediatric Annals 2016; 45(2) doi: 10.3928/00904481-20160113-01
108
Sherry Zhang, Chunxia Lu, Arun K. Das, Anil K. Pasupulati, Ram K. Menon. Abrogation of GH action in Kupffer cells results in increased hepatic CD36 expression and exaggerated nonalcoholic fatty liver disease. Growth Hormone & IGF Research 2018;  doi: 10.1016/j.ghir.2018.10.001
109
Gillian Elvira Seipalla, Nurahmi Nurahmi, Ibrahim Abd Samad. Analysis of Liver Fibrosis Degree with APRI Score and FIB-4 Index on Patients with Non-Alcoholic Fatty Liver Disease. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 2020; 26(2) doi: 10.24293/ijcpml.v26i2.1414
110
Mohammad Hosein Farzaei, Amit Kumar Singh, Ramesh Kumar, Courtney R. Croley, Abhay K. Pandey, Ericsson Coy-Barrera, Jayanta Kumar Patra, Gitishree Das, Rout George Kerry, Giuseppe Annunziata, Gian Carlo Tenore, Haroon Khan, Matteo Micucci, Roberta Budriesi, Saeideh Momtaz, Seyed Mohammad Nabavi, Anupam Bishayee. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders. International Journal of Molecular Sciences 2019; 20(19) doi: 10.3390/ijms20194957
111
Yang Liu, Yiping Li, Jue Wang, Lili Yang, Xiao Yu, Ping Huang, Haiyan Song, Peiyong Zheng. Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway. BMC Complementary Medicine and Therapies 2022; 22(1) doi: 10.1186/s12906-022-03697-9
112
Paulo Sérgio Loubet Filho, Thayná Gil Santos, Vitória Helena de Oliveira Teixeira Reis, Cynthia Monteiro Santee, Matheus Pereira da Costa, Camila Jordão Cândido, Wander Fernando de Oliveira Filiú, Luciane Candeloro Portugal, Elisvânia Freitas dos Santos. Campomanesia sp. flour attenuates non‐alcoholic fatty liver disease on rats fed with a hypercaloric diet. Journal of Animal Physiology and Animal Nutrition 2020; 104(5) doi: 10.1111/jpn.13361
113
. 2019;  doi: 10.70675/5fe7950dz1147z4d64z9b9bz87bfd1d3ae35
114
A Lum Han. Association between Non-Alcoholic Fatty Liver Disease and Dietary Habits, Stress, and Health-Related Quality of Life in Korean Adults. Nutrients 2020; 12(6) doi: 10.3390/nu12061555
115
Renald Blundell, Joseph Ignatius Azzopardi. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021;  doi: 10.1016/B978-0-12-816488-4.00005-X
116
Surbhi Dogra, Debajyoti Das, Sujay K. Maity, Avishek Paul, Priya Rawat, P. Vineeth Daniel, Kausik Das, Souveek Mitra, Partha Chakrabarti, Prosenjit Mondal. Liver-Derived S100A6 Propels β-Cell Dysfunction in NAFLD. Diabetes 2022; 71(11) doi: 10.2337/db22-0056
117
Mazen Noureddin, José M Mato, Shelly C Lu. Nonalcoholic fatty liver disease: Update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Experimental Biology and Medicine 2015; 240(6) doi: 10.1177/1535370215579161
118
Oriol Juanola, Sebastián Martínez-López, Rubén Francés, Isabel Gómez-Hurtado. Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. International Journal of Environmental Research and Public Health 2021; 18(10) doi: 10.3390/ijerph18105227
119
Yamei Li, Ping Qi, Si-Yuan Song, Yiping Wang, Hailian Wang, Peng Cao, Yu’e Liu, Yi Wang. Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease. Biomedicine & Pharmacotherapy 2024; 174 doi: 10.1016/j.biopha.2024.116585
120
Rishi Philip Mathew, Sudhakar K Venkatesh. Imaging diffuse liver disease. Applied Radiology 2019;  doi: 10.37549/AR2604
121
Green Coffee Bean Extract in Human Health. 2016;  doi: 10.1201/9781315371153-10
122
Jake P Mann, Rajiv Goonetilleke, Pat McKiernan. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. Archives of Disease in Childhood 2015; 100(7) doi: 10.1136/archdischild-2014-307985
123
Carla Sá, Ana Rita Oliveira, Cátia Machado, Marisa Azevedo, Cristina Pereira-Wilson. Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside. Evidence-Based Complementary and Alternative Medicine 2015; 2015 doi: 10.1155/2015/647832
124
Ahmed Ba‐Ssalamah, Nina Bastati, Andreas Wibmer, Romana Fragner, Jacqueline C. Hodge, Michael Trauner, Christian J. Herold, Mustafa R. Bashir, Bernard E. Van Beers. Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?. Journal of Magnetic Resonance Imaging 2017; 45(3) doi: 10.1002/jmri.25518
125
Richard C Chang, Yikai Huang, Kaitlin To, Ryan Scott Whitlock, Katelyn Uyen Nguyen, Michelle Clara Joemon, Miranda Lopez, Kritin Guy Deeprompt, Toshi Shioda, Bruce Blumberg. Transgenerational Effects of the Obesogen Tributyltin on Metabolic Health in Mice: Interactions With a Western Diet. Endocrinology 2025; 166(5) doi: 10.1210/endocr/bqaf063
126
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena N Shirokova, Elena I Vovk, Kirill M Starostin. Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia. BMJ Open Gastroenterology 2020; 7(1) doi: 10.1136/bmjgast-2019-000368
127
Arefe Nemati, Zeinab Nikniaz, Ali Mota. Effects of Resveratrol Supplementation on Nonalcoholic Fatty Liver Disease Management. Topics in Clinical Nutrition 2023; 38(2) doi: 10.1097/TIN.0000000000000314
128
Tuukka Taipale, Ilkka Seppälä, Emma Raitoharju, Nina Mononen, Leo-Pekka Lyytikäinen, Thomas Illig, Melanie Waldenberger, Markus Juonala, Nina Hutri-Kähönen, Niku Oksala, Mika Kähönen, Olli Raitakari, Terho Lehtimäki. Fatty liver is associated with blood pathways of inflammatory response, immune system activation and prothrombotic state in Young Finns Study. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28563-y
129
Shaheen Tomah, Naim Alkhouri, Osama Hamdy. Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?. Clinical Diabetes and Endocrinology 2020; 6(1) doi: 10.1186/s40842-020-00097-1
130
Sharareh Kamfar, Bardia Danaei, Samane Rahimi, Vahide Zeinali. Novel blood and tissue-based mitochondrial D-loop mutations detected in an Iranian NAFLD patient cohort. Mitochondrion 2024; 77 doi: 10.1016/j.mito.2024.101888
131
Anthony Pinçon, Olivia De Montgolfier, Nilay Akkoyunlu, Caroline Daneault, Philippe Pouliot, Louis Villeneuve, Frédéric Lesage, Bernard I. Levy, Nathalie Thorin-Trescases, Éric Thorin, Matthieu Ruiz. Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice. Metabolites 2019; 9(5) doi: 10.3390/metabo9050104
132
Isabel Freitas, Eleonora Boncompagni, Eleonora Tarantola, Cristian Gruppi, Vittorio Bertone, Andrea Ferrigno, Gloria Milanesi, Rita Vaccarone, M. Enrica Tira, Mariapia Vairetti, Francisco Javier Romero. In Situ Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine‐ and Choline‐Deficient Diet. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/9307064
133
Syed Mushfiq, Ghulam Nabi Yatoo, Bilal Ahmad Mir, Zubaida Rasool. Two faces of the same coin non alcoholic fatty liver disease; with and without diabetes: Comparative clinico pathological analysis: A cross sectional observational study. Journal of Family Medicine and Primary Care 2025; 14(1) doi: 10.4103/jfmpc.jfmpc_1208_23
134
Lucas Zangerolamo, Gabriela Moreira Soares, Jean Franciesco Vettorazzi, Maria Esméria do Amaral, Everardo Magalhães Carneiro, Sara Teresinha Olalla-Saad, Antonio Carlos Boschero, Helena Cristina Barbosa-Sampaio. ARHGAP21 deficiency impairs hepatic lipid metabolism and improves insulin signaling in lean and obese mice. Canadian Journal of Physiology and Pharmacology 2019; 97(11) doi: 10.1139/cjpp-2018-0691
135
Chen-Cuang Yao, Yu-Xing Tong, Hua Jiang, Dan-Ru Yang, Xue-Jun Zhang, Ping Zhang, Li Su, Yan-Ying Zhao, Zheng-Wang Chen. Native polypeptide vglycin prevents nonalcoholic fatty liver disease in mice by activating the AMPK pathway. Journal of Functional Foods 2020; 73 doi: 10.1016/j.jff.2020.104110
136
Zifeng Yang, Ruifeng Tian, Xiao-Jing Zhang, Jingjing Cai, Zhi-Gang She, Hongliang Li. Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction. Frontiers in Cardiovascular Medicine 2023; 9 doi: 10.3389/fcvm.2022.1120085
137
Mi-Ock Baek, Young-Mo Yang, Eun-Young Kwon, Ji-Young Choi. Rosmarinic Acid Ameliorates Obesity-Associated Metabolic Disturbances and Hepatic Steatosis in Mice with High-Fat Diet-Induced Obesity. International Journal of Molecular Sciences 2026; 27(14) doi: 10.3390/ijms27146530
138
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot study. Revista de Gastroenterología de México (English Edition) 2021; 86(2) doi: 10.1016/j.rgmxen.2020.04.008
139
Victoria T. Isaksen, Maria A. Larsen, Rasmus Goll, Jon R. Florholmen, Eyvind J. Paulssen. Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects. BMC Obesity 2016; 3(1) doi: 10.1186/s40608-016-0118-0
140
Maria Luíza R. P. Lima, Laura H. R. Leite, Carolina R. Gioda, Fabíola O. P. Leme, Claudia A. Couto, Cândido C. Coimbra, Virginia H. R. Leite, Teresa Cristina A. Ferrari. A Novel Wistar Rat Model of Obesity-Related Nonalcoholic Fatty Liver Disease Induced by Sucrose-Rich Diet. Journal of Diabetes Research 2016; 2016 doi: 10.1155/2016/9127076
141
Bronwen Williams, Nurun Tania, Lynsey Corless. Non-alcoholic fatty liver disease (NAFLD): survey of awareness and understanding among professionals in secondary care. Gastrointestinal Nursing 2019; 17(Sup6) doi: 10.12968/gasn.2019.17.Sup6.S22
142
Somayyeh Asghari, Soudabeh Hamedi‐Shahraki, Farshad Amirkhizi. Systemic redox imbalance in patients with nonalcoholic fatty liver disease. European Journal of Clinical Investigation 2020; 50(4) doi: 10.1111/eci.13211
143
Satoshi HIRAKO, HyounJu KIM, Yuzuru IIZUKA, Akiyo MATSUMOTO. Fish oil consumption prevents hepatic lipid accumulation induced by high-cholesterol feeding in obese KK mice. Biomedical Research 2024; 45(1) doi: 10.2220/biomedres.45.33
144
Hassan H A-Kader. Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD). Expert Review of Gastroenterology & Hepatology 2017; 11(10) doi: 10.1080/17474124.2017.1343144
145
Alabagi Abdulla, Charity Reynolds, H Hesham A-Kader. Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure. European Medical Journal 2016;  doi: 10.33590/emj/10314771
146
Tian Shen, Bilin Xu, Tao Lei, Lin Chen, Cuiping Zhang, Zhenhua Ni. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway. Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6554
147
Min-Yu Chung, Hyo-Jin Kim, Hyo-Kyoung Choi, Jae Ho Park, Jin-Taek Hwang. Black Mulberry Extract Elicits Hepatoprotective Effects in Nonalcoholic Fatty Liver Disease Models by Inhibition of Histone Acetylation. Journal of Medicinal Food 2021; 24(9) doi: 10.1089/jmf.2021.K.0048
148
Hamza Hadi, Roberto Vettor, Marco Rossato. Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth?. Antioxidants 2018; 7(1) doi: 10.3390/antiox7010012
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.